                         SEQUENCE LISTING

<110>  Ascendis Pharma A/S
 
<120>  Conjugation Method for Carrier-Linked Prodrugs

<130>  CPX70461PC

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial random coil

<400>  1

Gly Gly Pro Gly Gly Pro Gly Pro Gly Gly Pro Gly Gly Pro Gly Pro 
1               5                   10                  15      


Gly Gly Pro Gly 
            20  


<210>  2
<211>  80
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial random coil

<400>  2

Gly Gly Pro Gly Gly Pro Gly Pro Gly Gly Pro Gly Gly Pro Gly Pro 
1               5                   10                  15      


Gly Gly Pro Gly Gly Gly Pro Gly Gly Pro Gly Pro Gly Gly Pro Gly 
            20                  25                  30          


Gly Pro Gly Pro Gly Gly Pro Gly Gly Gly Pro Gly Gly Pro Gly Pro 
        35                  40                  45              


Gly Gly Pro Gly Gly Pro Gly Pro Gly Gly Pro Gly Gly Gly Pro Gly 
    50                  55                  60                  


Gly Pro Gly Pro Gly Gly Pro Gly Gly Pro Gly Pro Gly Gly Pro Gly 
65                  70                  75                  80  


<210>  3
<211>  38
<212>  PRT
<213>  Homo sapiens


<220>
<221>  DISULFID
<222>  (22)..(38)

<400>  3

Leu Gln Glu His Pro Asn Ala Arg Lys Tyr Lys Gly Ala Asn Lys Lys 
1               5                   10                  15      


Gly Leu Ser Lys Gly Cys Phe Gly Leu Lys Leu Asp Arg Ile Gly Ser 
            20                  25                  30          


Met Ser Gly Leu Gly Cys 
        35              


